• News Releases

EY announces John Figueroa and Mark Peterson of Genoa Entrepreneur Of The Year® 2017 Award finalist in the Pacific Northwest

Apr 26th, 2017

EY today announced that John Figueroa, CEO, and Mark Peterson, Chief Commercial Officer, of Genoa, a Qol Healthcare Company, are finalists for the Entrepreneur Of The Year® 2017 Award in the Pacific Northwest. The awards program, which is celebrating its 31st year, recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Figueroa and Peterson were selected as finalists by a panel of independent judges. Award winners will be announced at a special gala event on June 9, 2017 at the Hyatt Regency Bellevue. “Being part of an organization that makes a difference in the lives of people with serious mental illness and is successful as a business, is truly a privilege,” said Figueroa. “We couldn’t be more pleased to be recognized among so many other notable business luminaries in the Pacific Northwest,” he said. Now in its 31st year, the program has expanded to recognize business leaders in over 145 cities and more than 60 countries throughout the world.  Read the full press release here.

Recent Posts


  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...